![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication July 29, 2005.
Revised September 30, 2005.
Accepted for publication September 30, 2005.
Most human hepatocyte cell lines lack a substantial set of liver-specific functions, especially
major cytochrome P450 (CYP)-related enzyme activities, making them unrepresentative of in
vivo hepatocytes. We have used the HepaRG cells derived from a human hepatocellular
carcinoma, that exhibit a high differentiation pattern after 2 weeks at confluency to determine
whether they could mimic human hepatocytes for drug metabolism and toxicity studies. We
show that when passaged at low density these cells reversed to an undifferentiated
morphology, actively divided and after having reached confluency formed typical hepatocytelike
colonies surrounded by biliary epithelial-like cells. By contrast, when seeded at high
density, hepatocyte-like clusters retained their typical differentiated morphology. Transcripts
of various nuclear receptors (AhR, PXR, CAR, PPAR
), CYPs (1A2, 2C9, 2D6, 2E1, 3A4),
phase 2 enzymes (UGT1A1, GSTA1, GSTA4, GSTM1) and other liver-specific functions
were estimated by RT-qPCR and found to be expressed for most of them at comparable levels
in both confluent differentiated and high density differentiated HepaRG cells and in cultured
primary human hepatocytes. For several transcripts the levels were strongly increased in
presence of 2% dimethylsulfoxide. Measurement of basal activities of several CYPs and their
response to prototypical inducers as well as analysis of metabolic profiles and cytotoxicity of
several compounds confirmed the functional resemblance of HepaRG cells to primary
cultured human hepatocytes. In conclusion, HepaRG cells constitute the first human hepatoma
cell line expressing high levels of the major CYPs involved in xenobiotic metabolism and
represent a reliable surrogate to human hepatocytes for drug metabolism and toxicity studies.
Key words:
CAR, cytochrome P450, enzyme induction, glutathione transferases, hepatocytes, in vitro toxicity assays, PXR
This article has been cited by other articles:
|
|
 |
|
  V. Chu, H. J. Einolf, R. Evers, G. Kumar, D. Moore, S. Ripp, J. Silva, V. Sinha, M. Sinz, and A. Skerjanec In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective Drug Metab. Dispos., July 1, 2009; 37(7): 1339 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F. McGinnity, G. Zhang, J. R. Kenny, G. A. Hamilton, S. Otmani, K. R. Stams, S. Haney, P. Brassil, D. M. Stresser, and R. J. Riley Evaluation of Multiple in Vitro Systems for Assessment of CYP3A4 Induction in Drug Discovery: Human Hepatocytes, Pregnane X Receptor Reporter Gene, and Fa2N-4 and HepaRG Cells Drug Metab. Dispos., June 1, 2009; 37(6): 1259 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Hantz, R. Parent, D. Durantel, P. Gripon, C. Guguen-Guillouzo, and F. Zoulim Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells J. Gen. Virol., January 1, 2009; 90(1): 127 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Kanebratt and T. B. Andersson Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies Drug Metab. Dispos., July 1, 2008; 36(7): 1444 - 1452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gupta, G. M. Mugundu, P. B. Desai, K. E. Thummel, and J. D. Unadkat Intestinal Human Colon Adenocarcinoma Cell Line LS180 Is an Excellent Model to Study Pregnane X Receptor, but Not Constitutive Androstane Receptor, Mediated CYP3A4 and Multidrug Resistance Transporter 1 Induction: Studies with Anti-Human Immunodeficiency Virus Protease Inhibitors Drug Metab. Dispos., June 1, 2008; 36(6): 1172 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Josse, C. Aninat, D. Glaise, J. Dumont, V. Fessard, F. Morel, J.-M. Poul, C. Guguen-Guillouzo, and A. Guillouzo Long-Term Functional Stability of Human HepaRG Hepatocytes and Use for Chronic Toxicity and Genotoxicity Studies Drug Metab. Dispos., June 1, 2008; 36(6): 1111 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Guilbaud, G. Chadeuf, F. Avolio, A. Francois, P. Moullier, A. Recchia, and A. Salvetti Relative Influence of the Adeno-Associated Virus (AAV) Type 2 p5 Element for Recombinant AAV Vector Site-Specific Integration J. Virol., March 1, 2008; 82(5): 2590 - 2593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Kanebratt and T. B. Andersson HepaRG Cells as an in Vitro Model for Evaluation of Cytochrome P450 Induction in Humans Drug Metab. Dispos., January 1, 2008; 36(1): 137 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. O. Andrieux, A. Fautrel, A. Bessard, A. Guillouzo, G. Baffet, and S. Langouet GATA-1 Is Essential in EGF-Mediated Induction of Nucleotide Excision Repair Activity and ERCC1 Expression through ERK2 in Human Hepatoma Cells Cancer Res., March 1, 2007; 67(5): 2114 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.J. Tweats, A.D. Scott, C. Westmoreland, and P.L. Carmichael Determination of genetic toxicity and potential carcinogenicity in vitro--challenges post the Seventh Amendment to the European Cosmetics Directive Mutagenesis, January 1, 2007; 22(1): 5 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Sainz Jr. and F. V. Chisari Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells. J. Virol., October 1, 2006; 80(20): 10253 - 10257. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
